406 related articles for article (PubMed ID: 20067706)
1. Intranasal drug delivery: how, why and what for?
Pires A; Fortuna A; Alves G; Falcão A
J Pharm Pharm Sci; 2009; 12(3):288-311. PubMed ID: 20067706
[TBL] [Abstract][Full Text] [Related]
2. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.
Grassin-Delyle S; Buenestado A; Naline E; Faisy C; Blouquit-Laye S; Couderc LJ; Le Guen M; Fischler M; Devillier P
Pharmacol Ther; 2012 Jun; 134(3):366-79. PubMed ID: 22465159
[TBL] [Abstract][Full Text] [Related]
3. Nasal drug delivery in humans.
Bitter C; Suter-Zimmermann K; Surber C
Curr Probl Dermatol; 2011; 40():20-35. PubMed ID: 21325837
[TBL] [Abstract][Full Text] [Related]
4. Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs.
Oliveira P; Fortuna A; Alves G; Falcao A
Curr Drug Metab; 2016; 17(7):628-47. PubMed ID: 27048181
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
Hu X; Yue X; Wu C; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in drug delivery systems: intranasal drug delivery.
Agarwal V; Mishra B
Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
9. Strategies to facilitate or block nose-to-brain drug delivery.
Martins PP; Smyth HDC; Cui Z
Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
[TBL] [Abstract][Full Text] [Related]
10. [Intranasal delivery of systemic drugs: a new route for opioid drugs].
Devillier P; Grassin-Delyle S; Naline E; Buenestado A; Blouquit-Laye S; Advenier C
Therapie; 2010; 65(5):475-81. PubMed ID: 21144483
[TBL] [Abstract][Full Text] [Related]
11. The application of mucoadhesive polymers in nasal drug delivery.
Jiang L; Gao L; Wang X; Tang L; Ma J
Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
[TBL] [Abstract][Full Text] [Related]
12. Permeability issues in nasal drug delivery.
Arora P; Sharma S; Garg S
Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and solutions for nasal drug delivery - a narrative review.
Ulusoy S; Bayar Muluk N; Karpischenko S; Passali GC; Negm H; Passali D; Milkov M; Kopacheva-Barsova G; Konstantinidis I; Dilber M; Cingi C
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(2 Suppl):72-81. PubMed ID: 36524914
[TBL] [Abstract][Full Text] [Related]
14. Intranasal drug delivery to the central nervous system: present status and future outlook.
Tayebati SK; Nwankwo IE; Amenta F
Curr Pharm Des; 2013; 19(3):510-26. PubMed ID: 23116337
[TBL] [Abstract][Full Text] [Related]
15. Formulation and physiological factors influencing CNS delivery upon intranasal administration.
Vyas TK; Tiwari SB; Amiji MM
Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery: physicochemical and therapeutic aspects.
Costantino HR; Illum L; Brandt G; Johnson PH; Quay SC
Int J Pharm; 2007 Jun; 337(1-2):1-24. PubMed ID: 17475423
[TBL] [Abstract][Full Text] [Related]
17. The nasal delivery of systemic drugs.
Jones NS; Quraishi S; Mason JD
Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
[TBL] [Abstract][Full Text] [Related]
18. Nasal clearance in health and disease.
Illum L
J Aerosol Med; 2006; 19(1):92-9. PubMed ID: 16551220
[TBL] [Abstract][Full Text] [Related]
19. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Keller LA; Merkel O; Popp A
Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
[TBL] [Abstract][Full Text] [Related]
20. Nasal route for vaccine and drug delivery: Features and current opportunities.
Lobaina Mato Y
Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
